Literature DB >> 15994791

Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.

David Perez-Caballero1, Theodora Hatziioannou, Annie Yang, Simone Cowan, Paul D Bieniasz.   

Abstract

The tripartite motif 5alpha protein (TRIM5alpha) is one of several factors expressed by mammalian cells that inhibit retrovirus replication. Human TRIM5alpha (huTRIM5alpha) inhibits infection by N-tropic murine leukemia virus (N-MLV) but is inactive against human immunodeficiency virus type 1 (HIV-1). However, we show that replacement of a small segment in the carboxy-terminal B30.2/SPRY domain of huTRIM5alpha with its rhesus macaque counterpart (rhTRIM5alpha) endows it with the ability to potently inhibit HIV-1 infection. The B30.2/SPRY domain and an additional domain in huTRIM5alpha, comprising the amino-terminal RING and B-box components of the TRIM motif, are required for N-MLV restriction activity, while the intervening coiled-coil domain is necessary and sufficient for huTRIM5alpha multimerization. Truncated huTRIM5alpha proteins that lack either or both the N-terminal RING/B-Box or the C-terminal B30.2/SPRY domain form heteromultimers with full-length huTRIM5alpha and are dominant inhibitors of its N-MLV restricting activity, suggesting that homomultimerization of intact huTRIM5alpha monomers is necessary for N-MLV restriction. However, localization in large cytoplasmic bodies is not required for inhibition of N-MLV by huTRIM5alpha or for inhibition of HIV-1 by chimeric or rhTRIM5alpha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994791      PMCID: PMC1168745          DOI: 10.1128/JVI.79.14.8969-8978.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Use of a transient assay for studying the genetic determinants of Fv1 restriction.

Authors:  M Bock; K N Bishop; G Towers; J P Stoye
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.

Authors:  J Martin-Serrano; T Zang; P D Bieniasz
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

3.  Identification of the regions of Fv1 necessary for murine leukemia virus restriction.

Authors:  K N Bishop; M Bock; G Towers; J P Stoye
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  DNA deamination mediates innate immunity to retroviral infection.

Authors:  Reuben S Harris; Kate N Bishop; Ann M Sheehy; Heather M Craig; Svend K Petersen-Mahrt; Ian N Watt; Michael S Neuberger; Michael H Malim
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

5.  Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein.

Authors:  Guangxia Gao; Xuemin Guo; Stephen P Goff
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

6.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

7.  Restriction of multiple divergent retroviruses by Lv1 and Ref1.

Authors:  Theodora Hatziioannou; Simone Cowan; Stephen P Goff; Paul D Bieniasz; Greg J Towers
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

8.  Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism.

Authors:  Simone Cowan; Theodora Hatziioannou; Tshaka Cunningham; Mark A Muesing; Heinrich G Gottlinger; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

9.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

10.  A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.

Authors:  Melvyn W Yap; Sébastien Nisole; Jonathan P Stoye
Journal:  Curr Biol       Date:  2005-01-11       Impact factor: 10.834

View more
  144 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.

Authors:  Amanda Roa; Fumiaki Hayashi; Yang Yang; Maritza Lienlaf; Jing Zhou; Jiong Shi; Satoru Watanabe; Takanori Kigawa; Shigeyuki Yokoyama; Christopher Aiken; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

3.  A new functional role of HIV-1 integrase during uncoating of the viral core.

Authors:  Marisa S Briones; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

4.  Hexagonal assembly of a restricting TRIM5alpha protein.

Authors:  Barbie K Ganser-Pornillos; Viswanathan Chandrasekaran; Owen Pornillos; Joseph G Sodroski; Wesley I Sundquist; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

5.  Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.

Authors:  Jenny L Anderson; Edward M Campbell; Xiaolu Wu; Nick Vandegraaff; Alan Engelman; Thomas J Hope
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

7.  Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity.

Authors:  David Perez-Caballero; Theodora Hatziioannou; Fengwen Zhang; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

8.  Retroviral restriction factor TRIM5alpha is a trimer.

Authors:  Claudia C Mische; Hassan Javanbakht; Byeongwoon Song; Felipe Diaz-Griffero; Matthew Stremlau; Bettina Strack; Zhihai Si; Joseph Sodroski
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.

Authors:  Haihan Song; Emi E Nakayama; Masaru Yokoyama; Hironori Sato; Jay A Levy; Tatsuo Shioda
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.

Authors:  Ryuta Sakuma; Seiga Ohmine; Yasuhiro Ikeda
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.